| scholarly article | Q13442814 |
| P50 | author | Donald Ganem | Q66789604 |
| P2093 | author name string | H Wang | |
| B Herndier | |||
| D Ganem | |||
| D J Anderson | |||
| W Zhong | |||
| J Pudney | |||
| A T Haase | |||
| K A Staskus | |||
| R Renne | |||
| J Beneke | |||
| K Gebhard | |||
| P2860 | cites work | The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma | Q70122617 |
| Kaposi's sarcoma: an extensively disseminated form in young homosexual men | Q70480718 | ||
| Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells | Q71563744 | ||
| Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma | Q72633360 | ||
| Primary Characterization of a Herpesvirus Agent Associated with Kaposi’s Sarcoma | Q27636336 | ||
| Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma | Q28242984 | ||
| Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection | Q28299060 | ||
| Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas | Q28299069 | ||
| Angiogenic properties of human immunodeficiency virus type 1 Tat protein | Q34267637 | ||
| The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission | Q34388952 | ||
| Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? | Q34996973 | ||
| Localization of human herpes-like virus type 8 in vascular endothelial cells and perivascular spindle-shaped cells of Kaposi's sarcoma lesions by in situ hybridization | Q35773919 | ||
| Kaposi's Sarcoma in Uganda: Geographic and Ethnic Distribution | Q36039507 | ||
| Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma | Q37535731 | ||
| A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma | Q39435212 | ||
| Kaposi's sarcoma in recipients of renal transplants | Q39901148 | ||
| The utility of basal cell-specific anti-cytokeratin antibody (34 beta E12) in the diagnosis of prostate cancer. A review of 228 cases. | Q40398095 | ||
| Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma | Q40972068 | ||
| Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture | Q41225141 | ||
| Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma | Q41435232 | ||
| Simultaneous in situ detection of two mRNAs in the same cell using riboprobes labeled with biotin and 35S | Q41730149 | ||
| Human immunodeficiency virus-associated oral Kaposi's sarcoma. A heterogeneous cell population dominated by spindle-shaped endothelial cells | Q42754958 | ||
| Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients | Q43823829 | ||
| Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections | Q46869996 | ||
| Kaposi's Sarcoma–Associated Herpesvirus DNA Sequences in Prostate Tissue and Human Semen | Q59647839 | ||
| Risk of Kaposi's sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS | Q67514240 | ||
| Geographic and birth cohort associations of Kaposi's sarcoma among homosexual men in Canada | Q67980785 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 715-719 | |
| P577 | publication date | 1997-01-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells | |
| P478 | volume | 71 |
| Q39756815 | A Domain in the C-terminal region of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated Herpesvirus affects transcriptional activation and binding to nuclear heterochromatin |
| Q35382266 | A Kaposi's Sarcoma-Associated Herpesvirus-Encoded Ortholog of MicroRNA miR-155 Induces Human Splenic B-Cell Expansion in NOD/LtSz-scid IL2Rγ null Mice |
| Q33784966 | A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus |
| Q33815534 | A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. |
| Q40015547 | A herpesvirus of rhesus monkeys related to the human Kaposi's sarcoma-associated herpesvirus |
| Q33265370 | A novel KRAB-Zinc finger protein interacts with latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus and activates transcription via terminal repeat sequences |
| Q40106826 | A potential alpha-helix motif in the amino terminus of LANA encoded by Kaposi's sarcoma-associated herpesvirus is critical for nuclear accumulation of HIF-1alpha in normoxia |
| Q33559699 | A viral gene that activates lytic cycle expression of Kaposi’s sarcoma-associated herpesvirus |
| Q35133282 | AIDS - Associated Kaposi's Sarcoma: A Double Jeopardy |
| Q36893107 | AIDS-associated Kaposi's sarcoma: is there still a role for interferon alfa? |
| Q30863867 | Aberrant herpesvirus-induced polyadenylation correlates with cellular messenger RNA destruction |
| Q36546891 | Acquired immunodeficiency syndrome-related malignancies in the era of highly active antiretroviral therapy |
| Q36845797 | Activation of Akt through gp130 receptor signaling is required for Kaposi's sarcoma-associated herpesvirus-induced lymphatic reprogramming of endothelial cells |
| Q26743368 | Activation of DNA Damage Response Induced by the Kaposi's Sarcoma-Associated Herpes Virus |
| Q39601922 | Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lytic replication by human cytomegalovirus |
| Q33854532 | Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis |
| Q41494543 | Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype |
| Q40686716 | Activation of human herpesvirus 8 open reading frame K5 independent of ORF50 expression |
| Q41682881 | Aetiology of Kaposi's sarcoma: current understanding and implications for therapy |
| Q22251046 | Aids-related malignancies |
| Q33647345 | Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells |
| Q34333300 | Altered patterns of cellular gene expression in dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirus |
| Q34541350 | Altering the Anti-inflammatory Lipoxin Microenvironment: a New Insight into Kaposi's Sarcoma-Associated Herpesvirus Pathogenesis |
| Q33717717 | An Sp1 response element in the Kaposi's sarcoma-associated herpesvirus open reading frame 50 promoter mediates lytic cycle induction by butyrate |
| Q96576951 | An oncogenic viral interferon regulatory factor upregulates CUB domain-containing protein 1 to promote angiogenesis by hijacking transcription factor lymphoid enhancer-binding factor 1 and metastasis suppressor CD82 |
| Q36098894 | Analysis of viral cis elements conferring Kaposi's sarcoma-associated herpesvirus episome partitioning and maintenance |
| Q34587184 | Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma |
| Q37544369 | Antiviral activity of (+)-rutamarin against Kaposi's sarcoma-associated herpesvirus by inhibition of the catalytic activity of human topoisomerase II. |
| Q39729318 | Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus |
| Q38388893 | At a Crossroads: Human DNA Tumor Viruses and the Host DNA Damage Response |
| Q35641404 | BH3 Profiling Reveals Selectivity by Herpesviruses for Specific Bcl-2 Proteins To Mediate Survival of Latently Infected Cells. |
| Q34292002 | Biology of Kaposi's sarcoma |
| Q34092739 | Brd2/RING3 interacts with a chromatin-binding domain in the Kaposi's Sarcoma-associated herpesvirus latency-associated nuclear antigen 1 (LANA-1) that is required for multiple functions of LANA-1. |
| Q77950865 | Cancer (or lack thereof) and viruses |
| Q36643922 | Cancers associated with Kaposi's sarcoma (KS) in AIDS: a link between KS herpesvirus and immunoblastic lymphoma |
| Q50420476 | Caspase-dependent suppression of type I interferon signaling promotes KSHV lytic replication |
| Q35675995 | Celecoxib Inhibits the Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus through Down-Regulation of RTA Expression by Inhibiting the Activation of p38 MAPK. |
| Q35885806 | Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? |
| Q38107726 | Cellular origin of Kaposi's sarcoma and Kaposi's sarcoma-associated herpesvirus-induced cell reprogramming |
| Q33647676 | Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease |
| Q33641552 | Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter |
| Q40302917 | Characterization of Kaposi's sarcoma-associated herpesvirus (KSHV) K1 promoter activation by Rta. |
| Q39673166 | Characterization of entry and infection of monocytic THP-1 cells by Kaposi's sarcoma associated herpesvirus (KSHV): role of heparan sulfate, DC-SIGN, integrins and signaling |
| Q34338900 | Characterization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. |
| Q35876734 | Characterization of ribonucleoprotein complexes containing an abundant polyadenylated nuclear RNA encoded by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) |
| Q40890887 | Characterization of the human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) oncogene, kaposin (ORF K12). |
| Q33781363 | Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin |
| Q34340317 | Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR |
| Q36538689 | Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency |
| Q35237492 | Chromatinization of the KSHV Genome During the KSHV Life Cycle |
| Q58700278 | Circular DNA tumor viruses make circular RNAs |
| Q34061960 | Comparative analysis of the transforming mechanisms of Epstein-Barr virus, Kaposi's sarcoma-associated herpesvirus, and Herpesvirus saimiri |
| Q39864020 | Comparative study of regulation of RTA-responsive genes in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. |
| Q56979156 | Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand e |
| Q37010247 | Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent declin |
| Q57789222 | Connivance, Complicity, or Collusion? The Role of Noncoding RNAs in Promoting Gammaherpesvirus Tumorigenesis |
| Q74475369 | Consistent polymerse chain reaction–single-strand conformation polymorphism pattern of human herpesvirus-8 in the course of classical Kaposi's sarcoma assumes its clonal origin |
| Q45754220 | Current Perspectives on the Molecular Pathogenesis of Virus-Induced Cancers in Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome |
| Q40267788 | Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression |
| Q33853499 | DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus |
| Q33844093 | DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters |
| Q39748116 | De novo infection and serial transmission of Kaposi's sarcoma-associated herpesvirus in cultured endothelial cells |
| Q36366060 | Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus |
| Q36691938 | Development of a fluorescence-based assay to screen antiviral drugs against Kaposi's sarcoma associated herpesvirus |
| Q24803532 | Development of real-time NASBA assays with molecular beacon detection to quantify mRNA coding for HHV-8 lytic and latent genes |
| Q39190555 | Diagnosis and Treatment of Kaposi Sarcoma |
| Q34331772 | Differential expression of viral Bcl-2 encoded by Kaposi's sarcoma-associated herpesvirus and human Bcl-2 in primary effusion lymphoma cells and Kaposi's sarcoma lesions |
| Q39602154 | Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters |
| Q35809792 | Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. |
| Q40126113 | Direct interactions of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta protein with the cellular protein octamer-1 and DNA are critical for specifying transactivation of a delayed-early promoter and stimulating viral reactivati |
| Q59350552 | Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA |
| Q33786189 | Distinct biology of Kaposi's sarcoma-associated herpesvirus from primary lesions and body cavity lymphomas |
| Q35131811 | Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma |
| Q47817986 | Do viral chemokines modulate Kaposi's sarcoma? |
| Q42131073 | Effects of NFkappaB activation on KSHV latency and lytic reactivation are complex and context-dependent |
| Q39683622 | Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis |
| Q34483652 | Efficient lytic induction of Kaposi's sarcoma-associated herpesvirus (KSHV) by the anthracyclines |
| Q40384607 | Envelope glycoprotein gB of Kaposi's sarcoma-associated herpesvirus is essential for egress from infected cells |
| Q33772234 | Epidemiology and pathogenesis of Kaposi's sarcoma-associated herpesvirus |
| Q33602244 | Epidemiology of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. |
| Q36684858 | Epigenetic diversity of Kaposi’s sarcoma–associated herpesvirus |
| Q34124015 | Establishment and maintenance of Kaposi's sarcoma-associated herpesvirus latency in B cells |
| Q40808131 | Establishment of AIDS-related primary-effusion lymphoma (PEL) cell lines that proliferate continuously without serum |
| Q36911706 | Ets-1 is required for the activation of VEGFR3 during latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. |
| Q37461513 | Evidence of inability of human cytomegalovirus to reactivate Kaposi's sarcoma-associated herpesvirus from latency in body cavity-based lymphocytes |
| Q36375588 | Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice |
| Q33234751 | Exploring the DNA binding interactions of the Kaposi's sarcoma-associated herpesvirus lytic switch protein by selective amplification of bound sequences in vitro |
| Q32163310 | Expression of Human Herpesvirus 8-Encoded Cyclin D in Kaposi's Sarcoma Spindle Cells |
| Q59647836 | Expression of human herpesvirus-8 (HHV-8) encoded pathogenic genes in Kaposi's Sarcoma (KS) primary lesions |
| Q38727204 | Expression of the Antisense-to-Latency Transcript Long Noncoding RNA in Kaposi's Sarcoma-Associated Herpesvirus |
| Q33815875 | Expression of the open reading frame 74 (G-protein-coupled receptor) gene of Kaposi's sarcoma (KS)-associated herpesvirus: implications for KS pathogenesis |
| Q35453657 | Extracellular Hsp90 serves as a co-factor for MAPK activation and latent viral gene expression during de novo infection by KSHV. |
| Q57029061 | FUS Negatively Regulates Kaposi's Sarcoma-Associated Herpesvirus Gene Expression |
| Q36167973 | Fine-Tuning of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway. |
| Q43181946 | Focal adhesion kinase is critical for entry of Kaposi's sarcoma-associated herpesvirus into target cells |
| Q41924146 | Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication |
| Q35184458 | Gamma herpesviruses: pathogenesis of infection and cell signaling |
| Q64230298 | Gammaherpesvirus Readthrough Transcription Generates a Long Non-Coding RNA That Is Regulated by Antisense miRNAs and Correlates with Enhanced Lytic Replication In Vivo |
| Q34390540 | Global metabolic profiling of infection by an oncogenic virus: KSHV induces and requires lipogenesis for survival of latent infection |
| Q35315503 | Glutamate secretion and metabotropic glutamate receptor 1 expression during Kaposi's sarcoma-associated herpesvirus infection promotes cell proliferation |
| Q40301190 | Glycolysis, Glutaminolysis, and Fatty Acid Synthesis Are Required for Distinct Stages of Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication |
| Q59193509 | HHV-6, HHV-7, HHV-8 in gingival biopsies from chronic adult periodontitis patients. A case-control study |
| Q44530827 | HHV‐8 infection status of AIDS‐unrelated and AIDS‐associated multicentric Castleman's disease |
| Q40174372 | HIV-associated Kaposi sarcoma and related diseases. |
| Q37707845 | HIV: An Epidemiologic study on Head and Neck Involvement in 50 Patients |
| Q35125631 | Herpes simplex virus type 2 or human herpesvirus 8 infection and prostate cancer risk: A meta-analysis |
| Q38180332 | Herpesvirus-encoded GPCRs: neglected players in inflammatory and proliferative diseases? |
| Q35787282 | High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma |
| Q38338235 | Highly selective escape from KSHV-mediated host mRNA shutoff and its implications for viral pathogenesis |
| Q38802773 | Hijacking GPCRs by viral pathogens and tumor |
| Q39752549 | Host Range of Kaposi's Sarcoma-Associated Herpesvirus in Cultured Cells |
| Q33295395 | Host transcript accumulation during lytic KSHV infection reveals several classes of host responses |
| Q46435255 | Human Herpesvirus 8 Infections |
| Q74302748 | Human Herpesvirus 8 Seroprevalence in Blood Donors and Lymphoma Patients From Different Regions of Italy |
| Q39582739 | Human Herpesvirus 8 in the Prostate Glands of Men with Kaposi’s Sarcoma |
| Q32020600 | Human Herpesvirus-8 ORF K8.1 Gene Encodes Immunogenic Glycoproteins Generated by Spliced Transcripts |
| Q33558299 | Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate |
| Q45754934 | Human herpes virus 8 (Kaposi’s sarcoma herpesvirus) |
| Q35083522 | Human herpesvirus 6 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus |
| Q41830756 | Human herpesvirus 8 (HHV-8) detected in two patients with Kaposi's sarcoma-like pyogenic granuloma |
| Q39606465 | Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate |
| Q34998791 | Human herpesvirus 8 glycoprotein B (gB), gH, and gL can mediate cell fusion |
| Q34237804 | Human herpesvirus 8 induces polyfunctional B lymphocytes that drive Kaposi's sarcoma |
| Q42669197 | Human herpesvirus 8 variants in sarcoid tissues |
| Q37888397 | Human herpesvirus 8-associated neoplasms: the roles of viral replication and antiviral treatment. |
| Q34976938 | Human herpesvirus 8-encoded vGPCR activates nuclear factor of activated T cells and collaborates with human immunodeficiency virus type 1 Tat. |
| Q34295801 | Human herpesvirus-8 and Kaposi's sarcoma: relationship with the multistep concept of tumorigenesis. |
| Q54111927 | Human herpesvirus-encoded kinase induces B cell lymphomas in vivo. |
| Q37478613 | Human immunodeficiency virus type 1 Tat accelerates Kaposi sarcoma-associated herpesvirus Kaposin A-mediated tumorigenesis of transformed fibroblasts in vitro as well as in nude and immunocompetent mice |
| Q34423461 | Human viruses and cancer. |
| Q39882833 | Identification and characterization of a new Kaposi's sarcoma-associated herpesvirus replication and transcription activator (RTA)-responsive element involved in RTA-mediated transactivation |
| Q39854011 | Identification and characterization of the promoter region of Kaposi's sarcoma-associated herpesvirus ORF11. |
| Q37640600 | Identification of HHV8 in early Kaposi's sarcoma: implications for Kaposi's sarcoma pathogenesis |
| Q39595507 | Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus |
| Q39594967 | Identification of human herpesvirus 8-specific cytotoxic T-cell responses. |
| Q33784194 | Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene |
| Q38414583 | Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV) |
| Q80212464 | Immune evasion by Kaposi's sarcoma-associated herpesvirus |
| Q39603164 | Immunoreceptor tyrosine-based activation motif-dependent signaling by Kaposi's sarcoma-associated herpesvirus K1 protein: effects on lytic viral replication |
| Q41839438 | In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. |
| Q33781299 | Increased efficiency of phorbol ester-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus during S phase |
| Q34022457 | Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma |
| Q40364647 | Inefficient establishment of KSHV latency suggests an additional role for continued lytic replication in Kaposi sarcoma pathogenesis. |
| Q41051439 | Infection of primary dermal microvascular endothelial cells by Kaposiʼs sarcoma-associated herpesvirus |
| Q37862425 | Infectious agents in human cancers: Lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV |
| Q35752316 | Inhibiting the Recruitment of PLCγ1 to Kaposi's Sarcoma Herpesvirus K15 Protein Reduces the Invasiveness and Angiogenesis of Infected Endothelial Cells |
| Q35702343 | Inhibition of infection and replication of human herpesvirus 8 in microvascular endothelial cells by alpha interferon and phosphonoformic acid |
| Q73965992 | Injection of human herpesvirus-8 in human skin engrafted on SCID mice induces Kaposi's sarcoma-like lesions |
| Q36296882 | Integrated systems biology analysis of KSHV latent infection reveals viral induction and reliance on peroxisome mediated lipid metabolism. |
| Q77966196 | Interleukin-4 receptor-directed cytotoxin therapy of AIDS-associated Kaposi's sarcoma tumors in xenograft model |
| Q36495258 | Interleukin-6 and its receptor: from bench to bedside |
| Q39610285 | Internal ribosome entry site regulates translation of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein |
| Q28757509 | Intracellular Kaposi's sarcoma-associated herpesvirus load determines early loss of immune synapse components |
| Q24807119 | Iron: a target for the management of Kaposi's sarcoma? |
| Q35703276 | K-bZIP Mediated SUMO-2/3 Specific Modification on the KSHV Genome Negatively Regulates Lytic Gene Expression and Viral Reactivation |
| Q40375800 | KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2. |
| Q26766437 | KSHV Genome Replication and Maintenance |
| Q42562294 | KSHV Induction of Angiogenic and Lymphangiogenic Phenotypes |
| Q37986049 | KSHV Rta Promoter Specification and Viral Reactivation |
| Q41622722 | KSHV and Kaposi's Sarcoma: The End of the Beginning? |
| Q33761091 | KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine |
| Q38418556 | KSHV downregulation of galectin-3 in Kaposi's sarcoma |
| Q35810446 | KSHV-Encoded MicroRNAs: Lessons for Viral Cancer Pathogenesis and Emerging Concepts |
| Q42177738 | KSHV-TK is a tyrosine kinase that disrupts focal adhesions and induces Rho-mediated cell contraction |
| Q39751014 | KSHV-encoded miRNAs target MAF to induce endothelial cell reprogramming |
| Q33627013 | KSHV-induced notch components render endothelial and mural cell characteristics and cell survival |
| Q27026000 | KSHV: pathways to tumorigenesis and persistent infection |
| Q39819343 | Kaposi sarcoma-associated herpes virus (KSHV) G protein-coupled receptor (vGPCR) activates the ORF50 lytic switch promoter: a potential positive feedback loop for sustained ORF50 gene expression |
| Q34470355 | Kaposi sarcoma-associated herpesvirus-associated malignancies: epidemiology, pathogenesis, and advances in treatment. |
| Q56999805 | Kaposi's Sarcoma and Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8): Where Are We Now? |
| Q53947567 | Kaposi's Sarcoma-Associated Herpesvirus |
| Q90319829 | Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Associated Disease in the AIDS Patient: An Update |
| Q36364597 | Kaposi's Sarcoma-Associated Herpesvirus Interleukin-6 Modulates Endothelial Cell Movement by Upregulating Cellular Genes Involved in Migration |
| Q47555904 | Kaposi's Sarcoma-Associated Herpesvirus K8 Is an RNA Binding Protein That Regulates Viral DNA Replication in Coordination with a Noncoding RNA. |
| Q43079558 | Kaposi's Sarcoma-Associated Herpesvirus Kaposin B Induces Unique Monophosphorylation of STAT3 at Serine 727 and MK2-Mediated Inactivation of the STAT3 Transcriptional Repressor TRIM28 |
| Q34997083 | Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Prolongs the Life Span of Primary Human Umbilical Vein Endothelial Cells |
| Q57169056 | Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication |
| Q77110928 | Kaposi's Sarcoma-Associated Herpesvirus-Encoded Oncogenes and Oncogenesis |
| Q92479600 | Kaposi's Sarcoma-Associated Herpesvirus-Encoded circRNAs Are Expressed in Infected Tumor Tissues and Are Incorporated into Virions |
| Q29394711 | Kaposi's Sarcoma–Associated Herpesvirus Immunoevasion and Tumorigenesis: Two Sides of the Same Coin? |
| Q40867526 | Kaposi's sarcoma and human herpesvirus-8 |
| Q36487309 | Kaposi's sarcoma and its associated herpesvirus |
| Q28472867 | Kaposi's sarcoma associated herpes virus (KSHV) induced COX-2: a key factor in latency, inflammation, angiogenesis, cell survival and invasion |
| Q34556281 | Kaposi's sarcoma associated herpesvirus (KSHV) or human herpesvirus 8 (HHV8). |
| Q44277985 | Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. |
| Q28221605 | Kaposi's sarcoma associated herpesvirus G-protein coupled receptor activation of cyclooxygenase-2 in vascular endothelial cells |
| Q41876173 | Kaposi's sarcoma associated herpesvirus tegument protein ORF75 is essential for viral lytic replication and plays a critical role in the antagonization of ND10-instituted intrinsic immunity. |
| Q35139294 | Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest |
| Q40173444 | Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression |
| Q35137826 | Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation |
| Q35077642 | Kaposi's sarcoma-associated herpesvirus infection of endothelial cells inhibits neutrophil recruitment through an interleukin-6-dependent mechanism: a new paradigm for viral immune evasion |
| Q42584460 | Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induces a strong bend on binding to terminal repeat DNA. |
| Q38305362 | Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays |
| Q33807199 | Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line |
| Q39590466 | Kaposi's sarcoma-associated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities |
| Q36484112 | Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: involvement of host cellular factors |
| Q42733497 | Kaposi's sarcoma-associated herpesvirus utilizes an actin polymerization-dependent macropinocytic pathway to enter human dermal microvascular endothelial and human umbilical vein endothelial cells |
| Q24543014 | Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats |
| Q35000871 | Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells |
| Q45749153 | Kaposi's sarcoma-associated herpesvirus: a new human tumor virus, but how? |
| Q33671160 | Kaposi's sarcoma-associated herpesvirus: epidemiology, virology, and molecular biology |
| Q34471059 | Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse |
| Q61641140 | Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents |
| Q34191778 | Kaposi's sarcoma: aetiopathogenesis, histology and clinical features |
| Q33668719 | Kaposin-B Enhances the PROX1 mRNA Stability during Lymphatic Reprogramming of Vascular Endothelial Cells by Kaposi's Sarcoma Herpes Virus |
| Q38125077 | Kaposi’s Sarcoma-Associated Herpesvirus ORF57 Protein: Exploiting All Stages of Viral mRNA Processing |
| Q33653424 | Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression |
| Q35044342 | Laboratory diagnosis of human herpesvirus 8 infection in humans |
| Q24670086 | Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus |
| Q34102739 | Latent KSHV Infection of Endothelial Cells Induces Integrin Beta3 to Activate Angiogenic Phenotypes |
| Q39406147 | Latent Kaposi's Sarcoma-Associated Herpesvirus Infection of Monocytes Downregulates Expression of Adaptive Immune Response Costimulatory Receptors and Proinflammatory Cytokines |
| Q35139228 | Latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells activates hypoxia-induced factors |
| Q33824419 | Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene |
| Q24307542 | Leucine Zipper Domain Is Required for Kaposi Sarcoma-associated Herpesvirus (KSHV) K-bZIP Protein to Interact with Histone Deacetylase and Is Important for KSHV Replication |
| Q39580911 | Limited Transmission of Kaposi’s Sarcoma-Associated Herpesvirus in Cultured Cells |
| Q82216168 | Localization of human herpesvirus type 8 in human sperms by in situ PCR |
| Q33817882 | Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. |
| Q40287215 | Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo |
| Q40578287 | Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover |
| Q35168476 | Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling |
| Q30306907 | Lytic replication of Kaposi's sarcoma-associated herpesvirus results in the formation of multiple capsid species: isolation and molecular characterization of A, B, and C capsids from a gammaherpesvirus |
| Q37568044 | Lytic replication-defective Kaposi's sarcoma-associated herpesvirus: potential role in infection and malignant transformation |
| Q34440669 | Macaque Homologs of EBV and KSHV Show Uniquely Different Associations with Simian AIDS-related Lymphomas |
| Q39550075 | Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells |
| Q39602182 | Mechanisms governing expression of the v-FLIP gene of Kaposi's sarcoma-associated herpesvirus |
| Q47547495 | Modified cross-linking, ligation, and sequencing of hybrids (qCLASH) identifies KSHV microRNA targets in endothelial cells |
| Q39623528 | Modulation of Interferon Regulatory Factor 5 Activities by the Kaposi Sarcoma-Associated Herpesvirus-Encoded Viral Interferon Regulatory Factor 3 Contributes to Immune Evasion and Lytic Induction |
| Q35158385 | Modulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors |
| Q40218296 | Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus |
| Q35124404 | Molecular Biology of Kaposi's Sarcoma-associated Herpesvirus and Related Oncogenesis |
| Q33560572 | Molecular biology of KSHV in relation to AIDS-associated oncogenesis |
| Q34013830 | Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication |
| Q35026060 | Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis |
| Q45732519 | Molecular indications for in vivo integration of the avian leukosis virus, subgroup J-long terminal repeat into the Marek's disease virus in experimentally dually-infected chickens |
| Q34234132 | Molecular piracy of Kaposi's sarcoma associated herpesvirus |
| Q39881608 | Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8 |
| Q39448554 | Multicenter comparison of PCR assays for detection of human herpesvirus 8 DNA in semen |
| Q39071650 | NF-κB activation coordinated by IKKβ and IKKε enables latent infection of Kaposi's sarcoma-associated herpesvirus |
| Q33718186 | NFAT and CREB Regulate Kaposi's Sarcoma-Associated Herpesvirus-Induced Cyclooxygenase 2 (COX-2) |
| Q34056503 | New developments in the etiopathogenesis and treatment of HIV-related Kaposi's sarcoma |
| Q38535445 | New insights into the expression and functions of the Kaposi's sarcoma-associated herpesvirus long noncoding PAN RNA. |
| Q48030000 | Novel Organizational Features, Captured Cellular Genes, and Strain Variability Within the Genome of KSHV/HHV8 |
| Q52641575 | Nucleolar stress enhances lytic reactivation of the Kaposi's sarcoma-associated herpesvirus |
| Q36246350 | ORF45 of Kaposi's Sarcoma-Associated Herpesvirus Inhibits Phosphorylation of Interferon Regulatory Factor 7 by IKKε and TBK1 as an Alternative Substrate |
| Q92278120 | PDGFRA defines the mesenchymal stem cell Kaposi's sarcoma progenitors by enabling KSHV oncogenesis in an angiogenic environment |
| Q35174136 | Pathogenesis of Kaposi's sarcoma |
| Q34333321 | Patterns of gene expression and a transactivation function exhibited by the vGCR (ORF74) chemokine receptor protein of Kaposi's sarcoma-associated herpesvirus |
| Q35784707 | Persistent activation of STAT3 by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. |
| Q42045465 | Phosphorylation and Polyubiquitination of Transforming Growth Factor β-Activated Kinase 1 Are Necessary for Activation of NF-κB by the Kaposi's Sarcoma-Associated Herpesvirus G Protein-Coupled Receptor |
| Q34651357 | Phosphorylation and function of the kaposin B direct repeats of Kaposi's sarcoma-associated herpesvirus |
| Q35689364 | Potent Antiviral Activity of Topoisomerase I and II Inhibitors against Kaposi's Sarcoma-Associated Herpesvirus |
| Q33432690 | Pre-micro RNA signatures delineate stages of endothelial cell transformation in Kaposi sarcoma. |
| Q37780705 | Prospects of a novel vaccination strategy for human gamma-herpesviruses |
| Q37727998 | Quantitative Analysis of the KSHV Transcriptome Following Primary Infection of Blood and Lymphatic Endothelial Cells |
| Q60952467 | Quantitative RNAseq analysis of Ugandan KS tumors reveals KSHV gene expression dominated by transcription from the LTd downstream latency promoter |
| Q42693319 | RFHVMn ORF73 is structurally related to the KSHV ORF73 latency-associated nuclear antigen (LANA) and is expressed in retroperitoneal fibromatosis (RF) tumor cells |
| Q52561164 | RNA epitranscriptomics: Regulation of infection of RNA and DNA viruses by N6 -methyladenosine (m6 A). |
| Q42919680 | Raman tweezers provide the fingerprint of cells supporting the late stages of KSHV reactivation |
| Q24673299 | Rapamycin is efficacious against primary effusion lymphoma (PEL) cell lines in vivo by inhibiting autocrine signaling |
| Q39284842 | Reactivation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus: An Update |
| Q34295807 | Reactivation and role of HHV-8 in Kaposi's sarcoma initiation |
| Q36454456 | Reactivation of Kaposi's sarcoma-associated herpesvirus from latency requires MEK/ERK, JNK and p38 multiple mitogen-activated protein kinase pathways |
| Q33916507 | Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency |
| Q32075378 | Reactivities of Human Sera with Human Herpesvirus-8-Infected BCBL-1 Cells and Identification of HHV-8-Specific Proteins and Glycoproteins and the Encoding cDNAs |
| Q35673143 | Recombinant Murine Gamma Herpesvirus 68 Carrying KSHV G Protein-Coupled Receptor Induces Angiogenic Lesions in Mice |
| Q46161853 | Relationship of Kaposi Sarcoma (KS)–Associated Herpesvirus Viremia and KS Disease in Zimbabwe |
| Q58481175 | Response from Schulz and Moore |
| Q35789145 | Restricted SIV replication in rhesus macaque lung tissues during the acute phase of infection |
| Q39321282 | RhoA-GTPase facilitates entry of Kaposi's sarcoma-associated herpesvirus into adherent target cells in a Src-dependent manner |
| Q24804288 | Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control study |
| Q92586530 | STING is dispensable during KSHV infection of primary endothelial cells |
| Q34774847 | SUMO and KSHV Replication |
| Q37366303 | Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy |
| Q36153930 | Sequence analysis of Kaposi sarcoma-associated herpesvirus (KSHV) microRNAs in patients with multicentric Castleman disease and KSHV-associated inflammatory cytokine syndrome. |
| Q39549930 | Sequence and genomic analysis of a Rhesus macaque rhadinovirus with similarity to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. |
| Q21245098 | Seroprevalence and risk factors of Kaposi's sarcoma-associated herpesvirus infection among the general Uygur population from south and north region of Xinjiang, China |
| Q36621229 | Sexual behaviour, STDs and risks for prostate cancer |
| Q33822504 | Signaling activities of gammaherpesvirus membrane proteins |
| Q40316592 | Sodium butyrate induces apoptosis and cell cycle arrest in primary effusion lymphoma cells independently of oxidative stress and p21(CIP1/WAF1) induction |
| Q38110398 | Soft tissue sarcomas—New approaches to diagnosis and classification |
| Q24791884 | Species-independent detection of RNA virus by representational difference analysis using non-ribosomal hexanucleotides for reverse transcription |
| Q33906970 | Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases |
| Q39776585 | Structural analysis of the Kaposi's sarcoma-associated herpesvirus K1 protein |
| Q39030014 | Structural proteins of Kaposi's sarcoma-associated herpesvirus antagonize p53-mediated apoptosis. |
| Q35124429 | Structure and function of latency-associated nuclear antigen |
| Q77103107 | Summary of the III International Consensus Symposium on Combined Antiviral Therapy |
| Q30311122 | Surface downregulation of major histocompatibility complex class I, PE-CAM, and ICAM-1 following de novo infection of endothelial cells with Kaposi's sarcoma-associated herpesvirus |
| Q33280632 | Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus |
| Q47606690 | TLR4-Mediated Inflammation Promotes KSHV-Induced Cellular Transformation and Tumorigenesis by Activating the STAT3 Pathway |
| Q24672438 | The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen |
| Q40273764 | The DNA architectural protein HMGB1 facilitates RTA-mediated viral gene expression in gamma-2 herpesviruses. |
| Q39579781 | The Immunogenic Glycoprotein gp35-37 of Human Herpesvirus 8 Is Encoded by Open Reading Frame K8.1 |
| Q36433542 | The KSHV viral IL-6 homolog is sufficient to induce blood to lymphatic endothelial cell differentiation. |
| Q41074986 | The KSHV/HHV8-Infected BCBL-1 Lymphoma Line Causes Tumors in SCID Mice but Fails to Transmit Virus to a Human Peripheral Blood Mononuclear Cell Graft |
| Q34494872 | The Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen |
| Q41932132 | The Kaposi's sarcoma-associated herpesvirus (KSHV) non-structural membrane protein K15 is required for viral lytic replication and may represent a therapeutic target. |
| Q35066362 | The Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis |
| Q39698307 | The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells |
| Q38335734 | The Kaposi's sarcoma-associated herpesvirus K-bZIP protein represses transforming growth factor beta signaling through interaction with CREB-binding protein |
| Q34359380 | The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter |
| Q57160789 | The RNA epitranscriptome of DNA viruses |
| Q77474503 | The Role of Kaposi’s Sarcoma-Associated Herpesvirus (KSHV/HHV-8) in Lymphoproliferative Diseases |
| Q35077558 | The Single RBP-Jκ Site within the LANA Promoter Is Crucial for Establishing Kaposi's Sarcoma-Associated Herpesvirus Latency during Primary Infection |
| Q39068717 | The cellular peptidyl-prolyl cis/trans isomerase Pin1 regulates reactivation of Kaposi's sarcoma-associated herpesvirus from latency |
| Q40416504 | The exonuclease and host shutoff functions of the SOX protein of Kaposi's sarcoma-associated herpesvirus are genetically separable |
| Q24304458 | The insulin receptor is essential for virus-induced tumorigenesis of Kaposi's sarcoma |
| Q33845947 | The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promoters |
| Q35104781 | The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus manipulates the activity of glycogen synthase kinase-3beta |
| Q39700420 | The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus permits replication of terminal repeat-containing plasmids. |
| Q34355092 | The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus supports latent DNA replication in dividing cells |
| Q34511161 | The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells |
| Q39860135 | The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. |
| Q40199723 | The minimal replicator element of the Kaposi's sarcoma-associated herpesvirus terminal repeat supports replication in a semiconservative and cell-cycle-dependent manner |
| Q34605505 | The molecular pathology of Kaposi's sarcoma-associated herpesvirus |
| Q37254263 | The product of Kaposi's sarcoma-associated herpesvirus immediate early gene K4.2 regulates immunoglobulin secretion and calcium homeostasis by interacting with and inhibiting pERP1. |
| Q35196615 | The role of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 regulator of transcription activation (RTA) in control of gene expression |
| Q42827481 | The unsulfated extracellular N-terminus of vGPCR reduces the tumorigenicity of hGRO-α in nude mice |
| Q34961799 | The viral KSHV chemokine vMIP-II inhibits the migration of Naive and activated human NK cells by antagonizing two distinct chemokine receptors |
| Q33653581 | Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice |
| Q41361941 | Three new human herpesviruses (HHV6, 7, and 8). |
| Q34349469 | Tissue specificity of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen (LANA/orf73) promoter in transgenic mice |
| Q42274743 | Tousled-like Kinases Modulate Reactivation of Gammaherpesviruses from Latency |
| Q64247511 | Towards Better Understanding of KSHV Life Cycle: from Transcription and Posttranscriptional Regulations to Pathogenesis |
| Q34069105 | Transcription Mapping of the Kaposi’s Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Genome in a Body Cavity-Based Lymphoma Cell Line (BC-1) |
| Q33837983 | Transcription activation of polyadenylated nuclear rna by rta in human herpesvirus 8/Kaposi's sarcoma-associated herpesvirus |
| Q33844645 | Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma. |
| Q39596534 | Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells |
| Q39683497 | Transcriptional downregulation of ORF50/Rta by methotrexate inhibits the switch of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 from latency to lytic replication. |
| Q34105482 | Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity. |
| Q40402402 | Two subclasses of Kaposi's sarcoma-associated herpesvirus lytic cycle promoters distinguished by open reading frame 50 mutant proteins that are deficient in binding to DNA |
| Q33711417 | Unraveling immunity to gamma-herpesviruses: a new model for understanding the role of immunity in chronic virus infection |
| Q34683604 | Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy |
| Q28472699 | Upregulation of xCT by KSHV-encoded microRNAs facilitates KSHV dissemination and persistence in an environment of oxidative stress |
| Q38256387 | Utilising proteomic approaches to understand oncogenic human herpesviruses (Review). |
| Q38026238 | Vaccine prospect of Kaposi sarcoma-associated herpesvirus |
| Q37237122 | Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial |
| Q37174446 | Viral Evasion and Manipulation of Host RNA Quality Control Pathways. |
| Q41984354 | Viral G protein-coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia? |
| Q39039032 | Viral gene expression and pathogenesis in three emerging diseases: HIV and AIDS; HTLV-I and HAM/TSP; and HHV-8 and Kaposi's sarcoma: Figure 1 |
| Q37033342 | Viral inhibitor of apoptosis vFLIP/K13 protects endothelial cells against superoxide-induced cell death. |
| Q37588733 | Viral interferon regulatory factors |
| Q34039189 | Viral latency and its regulation: lessons from the gamma-herpesviruses |
| Q34225991 | Virally encoded 7TM receptors |
| Q37744006 | Virion proteins of Kaposi's sarcoma-associated herpesvirus |
| Q40530093 | Visualization of a functional KSHV episome-maintenance protein LANA in living cells |
| Q39858771 | X-box binding protein 1 contributes to induction of the Kaposi's sarcoma-associated herpesvirus lytic cycle under hypoxic conditions |
Search more.